p53 Inhibits α6β4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB

Journal of Cell Biology

Volumn 147, Issue 5, 1999, Pages 1063-1072

  Bachelder, Robin E ^a,b   Ribick, Mark J ^a,b   Marchetti, Alessandra ^b   Falcioni, Rita ^c   Soddu, Silvia ^c   Davis, Kathryn R ^a,b   Mercurio, Arthur M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

AKT PKB; Caspase; Integrin; p53; Survival

Indexed keywords

CASPASE 3; INTEGRIN; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CASPASE 3; CASPASES; CELL SURVIVAL; COLORECTAL NEOPLASMS; ENZYME INDUCTION; ENZYME INHIBITORS; EPITOPES; HUMANS; INTEGRIN ALPHA6BETA4; INTEGRINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033615961     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.147.5.1063     Document Type: Article

References (79)

1. Ahmed, N.N., H.L. Grimes, A. Bellacosa, T.O. Chan, and P.N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:3627-3632.
2. Alessi, D.R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B.A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO (Eur. Mol. Biol. Organ.) J. 15:6541-6551.
3. Andjelkovic, M., D.R. Alessi, R. Meier, A. Fernandez, N.J. Lamb, M. Frech, P. Cron, P. Cohen, J.M. Lucocq, and B.A. Hemmings. 1997. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272: 31515-31524.
4. Bachelder, R.E., A. Marchetti, R. Falcioni, S. Soddu, and A.M. Mercurio. 1999. Activation of p53 function in carcinoma cells by the α6β4 integrin. J. Biol. Chem. 274:20733-20737.
5. Bellacosa, A., D. de Feo, A.K. Godwin, D.W. Bell, J.Q. Cheng, D.A. Altomare, M. Wan, L. Dubeau, G. Scambia, V. Masciullo, et al. 1995. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer. 64:280-285.
6. Berra, E., M.T. Diaz-Meco, and J. Moscat. 1998. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/ Akt pathway. J. Biol. Chem. 273:10792-10797.
7. Blume-Jensen, P., R. Janknecht, and T. Hunter. 1998. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr. Biol. 8:779-782.
8. Borradori, L., and A. Sonnenberg. 1996. Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr. Opin. Cell Biol. 8:647-656.
9. Boudreau, N., C.J. Sympson, Z. Werb, and M.J. Bissell. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267:891-893.
10. Cardone, M.H., N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1318-1321.
11. Chao, C., M.M. Lotz, A.C. Clarke, and A.M. Mercurio. 1996. A function for the integrin alpha6 beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res. 56:4811-4819.
12. Cheng, E.H., D.G. Kirsch, R.J. Chem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1966-1968.
13. Clarke, A.S., M.M. Lotz, C.C. Chao, and A.M. Mercurio. 1995. Activation of the p21 pathway of growth arrest and apoptosis by the β4 integrin cytoplasmic domain. J. Biol. Chem. 270:22673-22676.
14. Crowder, R.J., and R.S. Freeman. 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18:2933-2943.
15. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:231-241.
16. Davies, M.A., D. Koul, H. Dhesi, R. Berman, T.J. McDonnell, D. McConkey, W.K. Yung, and P.A. Steck. 1999. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 59:2551-2556.
17. Day, M.L., R.G. Foster, K.C. Day, X. Zhao, P. Humphrey, P. Swanson, A.A. Postigo, S.H. Zhang, and D.C. Dean. 1997. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem. 272:8125-8128.
18. Ding, H.F., G. McGill, S. Rowan, C. Schmaltz, A. Shimamura, and D.E. Fisher. 1998. Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J. Biol. Chem. 273:28378-28383.
19. Dowling, J., Q. Yu, and E. Fuchs. 1996. β4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J. Cell Biol. 134:559-572.
20. Dudek, H., S.R. Datta, T.F. Franke, M.J. Birnbaum, R. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:661-666.
21. Enari, M., R.V. Talanian, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:723-726.
22. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
23. Eves, E.M., W. Xiong, A. Bellacosa, S.G. Kennedy, P.N. Tsichlis, M.R. Rosner, and N. Hay. 1998. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18:2143-2152.
24. Falcioni, R., A. Sacchi, J. Resau, and S.J. Kennel. 1998. Monoclonal antibody to human carcinoma protein complex: quantitation in normal and tumor tissue. Cancer Res. 48:816-821.
25. Farrelly, N., Y.J. Lee, J. Oliver, C. Dine, and C.H. Streuli. 1999. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J. Cell Biol. 144:1337-1347.
26. Franke, T.F., S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, and P.N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727-736.
27. Frisch, S.M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.
28. Frisch, S.M., K. Vuori, F. Ruoslahti, and P.Y. Chan-Hui. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134:793-799.
29. Fuchs, E.J., K.A. McKenna, and A. Bedi. 1997. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res. 57:2550-2554.
30. Gerber, H.P., A. McMurtrey, J. Kowalski, M. Yan, B.A. Keyt, V. Dixit, and N. Ferrara. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273:30336-30343.
31. Gibson, S., S. Tu, R. Oyer, S.M. Anderson, and G.L. Johnson. 1999. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation. J. Biol. Chem. 274:17612-17618.
32. Green, K.J., and J.C. Jones. 1996. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:871-881.
33. Hemler, M.E., C. Crouse, and A. Sonnenberg. 1989. Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA betal subunit on certain cell lines. J. Biol. Chem. 264:6529-6535.
34. Hermeking, H., and D. Eick. 1994. Mediation of c-Myc-indueed apoptosis by p53. Science. 265:2091-2093.
35. Howlett, A.R., N. Bailey, C. Damsky, O.W. Petersen, and M.J. Bissell. 1995. Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma. J. Cell Sci. 108:1945-1957.
36. Ilic, D., E.A. Almeida, D.D. Schlaepfer, P. Dazin, S. Aizawa, and C.H. Damsky. 1998. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143:547-550.
37. Kajiji, S., R.N. Tamura, and V. Quaranta. 1989. A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO (Eur. Mol. Biol. Organ.) J. 8:673-680.
38. Kennel, S.J., L.J. Foote, R. Falcioni, A. Sonnenberg, C.J. Stringer, C. Crouse, and M.E. Hemler. 1989. Analysis of the minor-associated antigen TSP-180. Identity of alpha 6-beta 4 in the integrin superfamily. J. Biol. Chem. 264: 15515-15521.
39. Khwaja, A., P. Rodriguez-Viciana, S. Wennstrom, P.H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO (Eur. Mol. Biol. Organ.) J. 16:2783-2793.
40. Kim, S.Y., N.J. Bachman, T.S. Nair, S. Goldsmith, M. Liebert, H.B. Grossman, M.I. Lomax. and T.F., Carcy. 1997. Beta 4 integrin transaction of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4. Cancer Res. 57:38-42.
41. Kobayashi, T., U. Consoli, M. Andreeff, H. Shiku, A.B. Deisseroth, and W. Zhang. 1995. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene. 11: 2311-2316.
42. Komarova, E.A., M.V. Chernov, R. Franks, K. Wang, G. Armin, C.R. Zelnick, D.M. Chin, S.S. Bacus, G.R. Stark, and A.V. Gudkov. 1997. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO (Eur. Mol. Biol. Organ.) J. 16:1391-1400.
43. Lesoon-Wood, L.A., W.U. Kim, U.K. Kleinman, B.D. Weintraub, and A.J. Mixson. 1995. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther. 6:395-405.
44. Mainiero, F., C. Murgia, K.K. Wary, A.M. Curatola, A. Pepe, M. Blumemberg, J.K. Westwick, C. Der, and F.G. Giancotti. 1997. The coupling of α6β4 integrin to the ras-MAP kinase pathways mediated by she controls keratinocyte proliferation. EMBO (Eur. Mol. Biol. Organ.) J. 16:2365-2375.
45. Meredith, J.E., Jr., B. Fazeli, and M. A. Schwartz. 1993. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:953-961.
46. Merlo, G.R., F. Basolo, L. Fiore, L. Duboc, and N.E. Hynes. 1995. p53-Dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J. Cell Biol. 128:1185-1196.
47. Miao, J., S. Araki, K. Kaji, and H. Hayashi. 1997. Integrin β4 is involved in apoptotic signal transduction in endothelial cells. Biochem. Biophys. Res. Comm. 233:182-186.
48. Morgenstern, J.P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
49. Murgia, C., P. Blaikie, N. Kim, M. Dans, H.T. Petrie, and F.G. Giancotti. 1998. Cell cycle and adhesion defects in mice carrying a targeted deletion of the inteurin beta4 cytoplasmic domain. EMBO (Eur. Mol. Biol. Organ.) J. 17: 3940-3951.
50. Myers, M.P., I. Pass, I.H. Batty, J. Van der Kaay, J.P. Stolarov, B.A. Hemmings, M.H. Wigler, C.P. Downes, and N.K. Tonks. 1998. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. USA. 95:13513-13518.
51. Nagasawa, H., C.Y. Li, C.G. Maki, A.C. Imrich, and J.B. Little. 1995. Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res. 55:1842-1846.
52. Nigro, J.M., K.D. Aldape, S.M. Hess, and T.D. Tlsty. 1997. Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res. 57: 3635-3639.
53. O'Connor, K.L., L.M. Shaw, and A.M. Mercurio. 1998. Release of cAMP gating by the α6β4 integrin stimulates lamellae formation and the chemotactic migration of carcinoma cells. J. Cell Biol. 143:1749-1760.
54. Owen-Schaub, L.B., W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W.W. Zhang, F. Kruzel, et al. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
55. Qin, X.Q., D.M. Livingston, W.G. Kaelin Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:10918-10922.
56. Radeva, G., T. Petrocelli, E. Behrend, C. Leung-Hagesteijn, J. Filmus, J. Slingerland, and S. Dedhar. 1997. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 272: 13937-13944.
57. Ramaswamy, S., N. Nakamura, F. Vazquez, D.B. Batt, S. Perera, T.M. Roberts, and W.R. Sellers. 1999. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA. 96:2110-2115.
58. Rampalli, A.M., and P.S. Zelenka. 1995. Insulin regulates expression of c-fos and c-jun and suppresses apoptosis of lens epithelial cells. Cell Growth Differ. 6:945-953.
59. Rezniczek, G.A., J.M. de Pereda, M. Relpert, and G. Aiche. 1998. Linking integrin α6β4-based adhesion to the intermediate filament cytoskeleton: direct interaction between the β4 subunit and plectin at multiple molecular sites. J. Cell Biol. 141:2209-2225.
60. Rodeck, U., M. Jost, C. Kari, D.T. Shih, R.M. Lavker, D.L. Ewert, and P.J. Jensen. 1997. EGF-R dependent regulation of keratinocyte survival. J. Cell Sci. 110:113-121.
61. Sabbatini, P., and F. McCormick. 1999. Phosphoinositide 3-OH kinase (PI3K) and PKB/AKT delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 274:24263-24269.
62. Sakahira, H., M. Enari, and S. Nagata. 1998. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:96-99.
63. Shaw, L.M., I. Rabinovitz, H.F. Wang, A. Toker, and A.M. Mercurio. 1997. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell. 91:949-960.
64. Shi, Y., J.M. Glynn, L.J. Guilbert, T.G. Cotter, K.P. Bissonnette, and D.R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:212-214.
65. Siegel, J., M. Fritsche, S. Mai, G. Brandner, and R.D. Hess. 1995. Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfection. Oncogene. 11:1363-1370.
66. Skorski, T., A. Bellacosa, M. Nieborowska-Skorska, M. Majewski, R. Martinez, J.K. Choi, R. Trotta, P. Wlodarski, D. Perrotti, T.O. Chan, et al. 1997. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO (Eur. Mol. Biol. Organ.) J. 16:6151-6161.
67. Songyang, Z., D. Baltimore, L.C. Cantley, D.R. Kaplan, and T.F. Franke. 1997. Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:11345-11350.
68. Stambolic, V., A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Sidorovski, and T.W. Mak. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29-39.
69. Stromblad, S., J.C. Becker, M. Yebra, P.C. Brooks, and D.A. Cheresh. 1996. Suppression of p53 activity and p21WAF1/CTP1 expression by vascular cell integrin alphavbeta3 during angiogenesis. J. Clin. Invest. 98:426-433.
70. Sun, H., S.A. Santoro, and M.M. Zutter. 1998. Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: the role of the alpha6 and beta4 integrin subunits. Cancer Res. 58:2224-2233.
71. Sun, H., R. Lesche, D.M. Li, J. Liliental, H. Zhang, J. Gao, N. Gavrilova, B. Mueller, X. Liu, and H. Wu. 1999. PTEN modulates cell cycle progression and cell survival by regulating phosphalidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA. 96: 6199-6204.
72. Tang, D., and V.J. Kidd. 1998. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J. Biol. Chem. 273:28549-28552.
73. Tozeren, A., H.K. Kleinman, S. Wu, A.M. Mercurio, and S.W. Byers. 1994. Integrin alpha 6 beta 4 mediates dynamic interactions with laminin. J. Cell Sci. 107:3153-3163.
74. Wewer, U.M., L.M. Shaw, R. Albrechtsen, and A.M. Mercurio. 1997. The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151:1191-1198.
75. Widmann, C., S. Gibson, and G.L. Johnson. 1998. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:7141-7147.
76. Wu, X., and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA. 91:3602-3606.
77. Yu, Y., and J.B. Little. 1998. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58:4277-4281.
78. Zhang, W., X.Y. Guo, G.Y. Hu, W.B. Liu, J.W. Shay, and A.B. Deisseroth. 1994. A temperature-sensitive mutant of human p53. EMBO (Eur. Mol. Biol. Organ.). J. 13:2535-2544.
79. Zhang, Z., K. Vuori, J.C. Reed, and E. Ruoslahti. 1995. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 92:6161-6165.